ReviewHuman vaccines & immunotherapeutics2017

Harnessing benefit from targeting tumor associated carbohydrate antigens.

Thomas Kieber-Emmons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.